WILMINGTON– NeuroRx, a Wilmington clinical stage biopharma company developing the first drug regimen to treat severe bipolar depression, has retained J.P. Morgan as financial advisor. NeuroRx will begin enrolling patients […]
© 2024 Delaware Business Times